Rheumatology

New findings show that eosinophilic granulomatosis with polyangiitis (EGPA) patients in remission may safely reduce mepolizumab dosage, potentially easing long-term treatment burden.

A new study highlights anti-M3R antibodies as markers of a more aggressive clinical phenotype in systemic sclerosis, particularly affecting gastrointestinal health.

Patients with rheumatoid arthritis who stopped TNF inhibitors experienced fewer flares and treatment failures on methotrexate-tacrolimus therapy compared to methotrexate alone, with no major safety concerns.

New long-term study data suggest that patients with rheumatoid arthritis who achieve sustained disease control on baricitinib 4 mg may successfully taper to 2 mg, with the majority maintaining low disease activity or recapturing control if needed.

Asthma may raise the risk of developing osteoarthritis, with socially isolated or lonely individuals facing even greater susceptibility, according to a new large-scale cohort study.

A new study shows that even during the Omicron era, patients with systemic autoimmune rheumatic diseases face significant risks of hospitalisation due to COVID-19, particularly if unvaccinated or on immunosuppressive therapies.